TAMPA, Fla., Oct. 29, 2015 (GLOBE NEWSWIRE) — Trxade Group, Inc. (OTCQB:TRXD), a web-based pharmaceutical marketplace engaged in promoting and enabling trade among independent pharmacies and large pharmaceutical suppliers nationally, today announced that it has retained Investor Relations Partners (IRP) to expand the Company’s strategic investor relations program.
“This is an exciting time for Trxade Group and we believe with the help of Investor Relations Partners we will be able to more broadly and effectively communicate our story to the investment community,” said Suren Ajjarapu, Chairman and CEO of Trxade Group. “We have a number of exciting developments at Trxade Group driven by our proprietary technology that is designed to disrupt the multi-billion dollar pharmaceutical marketplace. Based on our current double-digit revenue growth rates and increasing demand for our services, we expect 2016 to be a profitable and breakthrough year for Trxade and its shareholders and look forward to updating the market on our progress as we continue to execute on our business plan,” concluded Mr. Ajjarapu.
Todd Markey, Vice President of Investor Relations Partners, said, “We are looking forward to communicating Trxade Group’s investment story to beyond its existing shareholder base and the health care sector. We believe Trxade Group should be of particular interest to value and earnings growth investors given our belief that the company is significantly undervalued when considering the vast potential of its proprietary disruptive technology and its outlook for accelerated growth and profitability,” concluded Mr. Markey.
To be added to Trxade Group’s investor lists, please contact Todd Markey at Investor Relations Partners at 818-280-6800 or via email at email@example.com.
About Investor Relations Partners, Inc.
Investor Relations Partners, Inc. (IRP) www.irpartnersinc.com is a full-service investor relations firm serving clients from Los Angeles to New York to China. The principals of IRP have received top industry awards for their investor relations programs for a number of high-profile companies, including, but not limited to, Starwood Hotels & Resorts Worldwide, ValueVision Media, Taro Pharmaceuticals, and LJ International. The firm’s principals have executed effective investor relations programs for dozens of public companies, ranging from emerging micro-cap companies to multinational corporations with market capitalizations in excess of $15 billion. For further information on IRP, please visit the firm’s Website at www.irpartnersinc.com.
About Trxade Group, Inc.
Headquartered in Tampa, Florida, Trxade Group, Inc. (OTCQB:TRXD) is a web based market platform that enables trade among healthcare buyers and sellers of pharmaceuticals, accessories and services. Founded in 2010, Trxade Group currently operates the trading platform with 4,600 registered members. Trxade Group also distributes directly private label pharmaceuticals through their 100% subsidiary, Westminster Pharmaceuticals LLC, to these registered members. For additional information please visit us at http://www.trxadegroup.com/
Disclaimer & Forward-Looking Statements
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements.
Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. Except as may be required by applicable law, we assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The company undertakes no duty to update forward-looking statements.
CONTACT: Investor Relations Contact: Max Pashman Phone: 818-280-6800 firstname.lastname@example.org